You need to enable JavaScript to run this app.
Recon: Eli Lilly to buy Morphic for $3.2 billion; White House appeals patent decision on HIV preventives
Recon
Jason Scott
Diagnostics/IVDs
Medical Devices
Pharmaceuticals
ReconJason Scott
Diagnostics/IVDsMedical DevicesPharmaceuticalsReconJason ScottDiagnostics/IVDsMedical DevicesPharmaceuticals